olmesartan medoxomil has been researched along with Oligohydramnios in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axt-Fliedner, R; Enzensberger, C; Eskef, K; Faas, D; Schwarze, A | 1 |
| Celentano, C; di Vera, E; Gallo, DP; Iannicco, A; Liberati, M; Prefumo, F | 1 |
1 review(s) available for olmesartan medoxomil and Oligohydramnios
| Article | Year |
|---|---|
Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Breech Presentation; Cesarean Section; Drug Substitution; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Infant; Infant, Newborn; Kidney; Oligohydramnios; Olmesartan Medoxomil; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Tetrazoles; Ultrasonography, Prenatal | 2012 |
1 other study(ies) available for olmesartan medoxomil and Oligohydramnios
| Article | Year |
|---|---|
Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker.
Topics: Angiotensin II Type 1 Receptor Blockers; Diuretics; Female; Fetal Diseases; Furosemide; Gestational Age; Humans; Imidazoles; Infant, Newborn; Male; Maternal Exposure; Oligohydramnios; Olmesartan Medoxomil; Pregnancy; Prenatal Diagnosis; Recovery of Function; Renal Insufficiency; Tetrazoles; Treatment Outcome | 2008 |